Tag: Anaphylactic Shock
11.1 Anaphylaxis Cases/Million Doses of Pfizer-BioNTech COVID-19 Vaccine Reported
Median interval from vaccine receipt to symptom onset was 13 minutes
ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies
Pfizer COVID-19 vaccine should not be administered to individuals with a known history of severe reaction to polyethylene glycol
Peanut-, Tree Nut-Induced Anaphylaxis Up on Halloween, Easter
Increases in risk for anaphylaxis induced by unknown nuts, peanuts among Canadian children
FDA Warns of Defective EpiPen Dangers
Devices may activate prematurely if the blue safety release is removed using sideways force
AAP: Antihistamine Use for Anaphylaxis May Delay Care Seeking
Odds of delay seeking medical care up with administration of antihistamines to child with anaphylaxis
Anaphylactic Reactions Tied to PICC Insertion With Magnetic Tip
Anaphylactic, anaphylactoid reactions linked to PICC insertion using Sherlock tip locating system
FDA Extends EpiPen Expiration Dates to Tackle Shortage
Shortages due to factors such as supply disruptions and manufacturer issues
FDA Approves First Generic EpiPen
Approval will address both rising costs and shortages of epinephrine
Anaphylaxis Is Rare Complication of Pregnancy
Estimated incidence is 1.6 per 100,000 maternities; often the result of a reaction to antibiotics
AAP: Epinephrine Admin Training Needed in Many Schools
In 2015 to 2016, 2.7 percent reported that epinephrine was administered by unlicensed staff
